In situ tissue regeneration holds great promise for regenerative medicine and tissue engineering applications. However, to achieve control over long-term and localised presence of biomolecules, certain barriers must be overcome. The aim of this study was to develop electrospun scaffolds for the fabrication of artificial vascular grafts that can be remodelled within a host by endogenous cell recruitment. We fabricated scaffolds by mixing appropriate proportions of linear poly (l-lactide-co-ε-caprolactone) (PLCL) and substance P (SP)-immobilised PLCL, using electrospinning to develop vascular grafts. Substance P was released in a sustained fashion from electrospun membranes for up to 30 d, as revealed by enzyme-linked immunosorbent assay. Immobilised SP remained bioactive and recruited human bone marrow-derived mesenchymal stem cells (hMSCs) in an in vitro Trans-well migration assay. The biocompatibility and biological performance of the scaffolds were evaluated by in vivo experiments involving subcutaneous scaffold implantations in SpragueDawley rats for up to 28 d followed by histological and immunohistochemical studies. Histological analysis revealed a greater extent of accumulative host cell infiltration and collagen deposition in scaffolds containing higher contents of SP than observed in the control group at both time points. We also observed the presence of a large number of laminin-positive blood vessels and Von Willebrand factor (vWF + ) cells in the explants containing SP. Additionally, scaffolds containing SP showed the existence of CD90 + and CD105 + MSCs. Collectively, these findings suggest that the methodology presented here may have broad applications in regenerative medicine, and the novel scaffolding materials can be used for in situ tissue regeneration of soft tissues.
Introduction
Vascular reconstruction remains a bottleneck clinical challenge for patients requiring coronary artery bypass, peripheral vascular surgery, or arteriovenous fistula. Over one million coronary revascularisation procedures are performed annually in the United States (Epstein et al., 2011) . Despite their utility in the absence of autologous vessel replacements, conventional prosthetic vascular graft materials present a huge risk of thrombosis and infection (Zilla et al., 1994; Pektok et al., 2008) . Alternatively, tissue engineering (TE) provides an attractive solution for vascular grafting by combining appropriate cell types and biomaterials, especially in the fabrication of small-diameter blood vessels (L'Heureux et al., 1998; Hoerstrup et al., 2006; Hashi et al., 2007) . As a cell source, stem cells are most frequently used because of their self-renewal ability and multi-potency. Such tissue-engineered vascular grafts (TEVGs) have been shown to remodel within a host either by the direct differentiation of stem cells into vascular cell types or through the recruitment of host cells by paracrine mechanisms (Pittenger et al., 1999; Gimblem et al., 2007; Karp and Leng Teo, 2009 ). However, ex vivo manipulations of stem cells have drawbacks for clinical applications such as poor cell survival and safety of culture medium supplements (Chen et al., 2011) .
To overcome these limitations, many researchers have tried to mimic endogenous wound healing processes by activating the host's own reparative capability (Askari et al., 2003; Schantz et al., 2007; Place et al., 2009; Hibino et al., 2011; Shao et al., 2012; Shafiq et al., 2015a) . These studies suggested the possibility of tissue regeneration by recruitment of endogenous stem cells to defected regions without transplantation of exogenous cells. In situ tissue regeneration uses scaffolds alone or scaffolds combined with bioactive factors to create a microenvironment that allows the body's own cells to infiltrate and take over the scaffold and eventually integrate into native tissues (Lee et al., 2010) . For efficient and successful in situ tissue regeneration, an appropriate number of host stem cells must be recruited. While stem cells could be recruited into tissue-engineered scaffolds when implanted, the small infiltrating population might not be enough for in situ tissue regeneration (Heissig et al., 2002; Chen et al., 2011; Nair et al., 2011; Wu et al., 2012) . Researchers have also exploited the in situ tissue regeneration for the formation of blood vessels in synthetic and biodegradable vascular scaffolds (Cho et al., 2006; Yokota et al., 2008; Hibino et al., 2011; De Visscher et al., 2012; Roh et al., 2010; Yu et al., 2012; www.ecmjournal.org
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PLCL scaffolds for in situ tissue regeneration 2013). A wide set of chemokines, including stromal cellderived factor-1 alpha (SDF-1α) and granulocyte colony stimulating factor (G-CSF), have been employed in vivo to recruit endogenous mesenchymal stem cells (MSCs), haematopoietic stem cells (HSCs), endothelial progenitor cells (EPCs), and smooth muscle progenitor cells for the regeneration of tissues. However, these molecules are known to be easily cleaved or damaged by proteolytic enzymes. Additionally, such molecules cannot be easily processed or conjugated with scaffolds because of their high molecular weight. Therefore, alternative candidates such as cationic antimicrobial peptides, bioactive lipids, and short peptides are greatly desired for in situ TE Shao et al., 2012; Karapetyan et al., 2013) . Substance P (SP), an 11-amino acid neuropeptide is released by sensory nerve fibres during tissue insult or bone marrow (BM) damage and is involved in neuroinflammation, cell proliferation, and wound healing (Nilsson et el., 1985; Lotz et al., 1987; Hiramoto et al., 1998; Kim et al., 2014) . It was previously reported that SP plays a novel role in mobilising MSCs from BM to wound sites, accelerating tissue repair. SP also possesses cellular and immune-modulatory effects and stimulates the production of various cytokines and growth factors, namely vascular endothelial growth factor (VEGF) and transforming growth factor-beta 1 (TGF-β), which can participate in a reparative process at the injury site Kohara et al., 2010; Amadesi et al., 2012; Jin et al., 2015; Hong et al., 2015) . These effects are expected by its local action, direct nerve innervation, direct cellular contact, and systematic effect through circulation. Noticeably, compared with other cytokines and growth factors, the injection of a very low dose of SP increased host cell mobilisation in peripheral blood . Moreover, in contrast to G-CSF, SP does not evoke any general pharmacological action or genetic toxicity and can be easily conjugated with biomaterials because of its small size (Momin et al., 1992; Hong et al., 2011; Kim et al., 2013) . In view of the multifunctional nature of both angiogenic and chemotactic activities, the use of SP seems necessary to reduce side effects and minimise the cost of TE in translational approaches. Although SP has been shown to promote diabetic and nondiabetic wound healing, bone regeneration, and ischaemic revascularisation, to the best of our knowledge, its effect in vascular grafts has not been reported. We believe that the multifunctional cellular and immune-modulatory nature of SP could be very useful for the remodelling of vascular grafts through host cell recruitment, immune-modulation, and cell proliferation and/or differentiation.
The objective of this study was therefore to develop electrospun (ES) scaffolds for the fabrication of artificial vascular grafts that can be remodelled within the host through endogenous cell mobilisation and recruitment. To accomplish these goals, we examined the following criteria. First, for the graft material, we chose a mechano-elastic and biodegradable poly (L-lactide-co-ε-caprolactone) (PLCL, 50:50) copolymer because degradation is essential for host remodelling and mechanical conditioning is recognised as an important remodelling cue for vascular regeneration (Jeong et al., 2004; Hassan et al., 2011) .
Elastomers efficiently transduce mechanical stimulation to cells (Wu et al., 2012) . PLCL copolymers have been applied as biomaterials for vascular TE because of their high elasticity (Mun et al., 2012; Mun et al., 2013) . In addition, PLCL has potential applications as a scaffolding material in the regeneration of soft tissues, including blood vessels, tendons, skin, oesophagus, and cardiac tissues. Second, for host cell recruitment, we incorporated SP in scaffolds and provided long-term and sustained presence. Because of the degradation of SP by neutral endopeptidases and its short half-life in vivo, maintaining the persistence of SP following systematic administration is a challenge Kim et al., 2014; Hong et al., 2014) . To improve the in vivo stability, SP sequences have so far been either physically adsorbed or chemically attached onto scaffold surfaces Kohara et al., 2010) . The strategies employed for covalent attachment are time-consuming and involve several activation and coupling steps (Kim and Park, 2006 ). An alternative approach to enhance biochemical signals is the bulk modification of polymers prior to the fabrication step (Kuhl et al., 1996; Cook et al., 1997; Shafiq et al., 2015b) . Our strategy relies on the direct conjugation of SP with the hydroxyl groups of the star-shaped PLCL (PLCL-SP). PLCL-SP may provide sustained release and localised presence of SP in scaffolds, recruit host cells, and could have immune-modulatory effects on the recruited cells within scaffolds. Third, to mimic extracellular matrix (ECM) architecture, we used ES since it enables the precise design of micro-and nanofibres. We varied the SP concentration to assess the host response to the vascular scaffolds containing different SP contents. To access biocompatibility and biological performance assessment, we implanted scaffolds subcutaneously in Sprague-Dawley (SD) rats (n = 16) for up to 28 d and performed histological and immunohistochemical studies. PLCL-SP can be processed to fabricate different ready-to-use shapes, such as membranes, scaffolds, and vascular grafts depending upon the final application of these materials for the in situ regeneration of soft tissues, such as blood vessels, tendons, skin, oesophagus, and bladder (Fig. 1A) .
Materials and Methods

Materials
L-lactide was purchased from PURAC Biomaterials (Seoul, Korea) and recrystallised in ethyl acetate before polymerisation. Caprolactone, 1-dodecanol (reagent grade, purity = 98 %), tin (II) bis (2-ethylhexanoate) (Sn(Oct) 2 , purity ≥ 99 %), N,N-dimethylformamide (DMF, purity ≥ 99.8 %), formamide (purity ≥ 99.5 %), dimethylsulphoxide (DMSO, purity ≥ 99.5 %), Dulbecco's phosphate-buffered saline (D-PBS), formalin solution (neutral buffered 10 %), 1,1'-carbonyldiimidazole (CDI; reagent grade), tripentaerythritol (TPE, technical grade), anhydrous dichloromethane (DCM), and ethanol were purchased from Sigma Aldrich (Seoul, South Korea). 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, purity = 99 %) was purchased from Tokyo Chemical Industry (Tokyo, Japan). Caprolactone was purified 
Synthesis of linear and eight-arm PLCL copolymers
Linear and star-shaped PLCL (50:50) copolymers were synthesised by ring opening polymerisation, as described in detail in our previous reports, with slight modifications (Mun et al., 2012; Shafiq et al., 2015b) . Briefly, 1-dodecanol and TPE were used as initiators to synthesise linear and star-shaped PLCL copolymers. Polymerisation was carried out in bulk in a 250 mL glass ampoule containing 100 mM L-lactide (LA), 100 mM ε-caprolactone (CL), 0.5 mM initiator, and 1.0 mM Sn(Oct) 2 . The ampoule was purged three times with nitrogen (N 2 ) and subjected to vacuum for 6 h. The sealed ampoule was then transferred to a pre-heated silicon oil bath (145 °C), and polymerisation was carried out for 24 h with mild stirring. The resultant copolymers were then dissolved in CHCl 3 , filtered through a 4.5 μm pore membrane, and precipitated into an excess of CH 3 OH.
Conjugation of SP with star-shaped PLCL copolymer SP was conjugated with eight armed star-shaped PLCL copolymers, as previously described, with slight modifications (Fig. 1B) (Shafiq et al., 2015b) . Briefly, star-shaped PLCL (M n ~ 67382, PDI = 1.80, 4.48 × 10 -5 moles) copolymer was dissolved in anhydrous DCM (10 mL) with continuous stirring under N 2 atmosphere for 2 h. Once PLCL was dissolved, CDI (7.16 × 10 -4 moles) dissolved in anhydrous DCM (2 mL) was added, and the reaction was continued for 6 h under N 2 atmosphere. PLCL-CDI was precipitated using excess ethanol and contents were dried in a vacuum oven for 48 h at room temperature. PLCL-CDI (1.48 × 10 -5 moles) was dissolved in anhydrous DCM and stirred for 3 h under N 2 atmosphere. SP (1.86 × 10 -6 moles) was dissolved in anhydrous DMSO and poured into the stirring PLCL-CDI solution (pH 8.2). The reaction was continued for 24 h at ambient temperature (25 °C). SP-conjugated star-shaped PLCL copolymers were precipitated with excess ethanol, washed with three times PBS, and dried in a vacuum oven at ambient temperature for 3 d. The vacuum-dried copolymer was stored at -20 °C for subsequent use.
Preparation of electrospun nanofibres
In this study, two types of electrospun mats were prepared by ES: PLCL and PLCL/PLCL-SP (SP content = 16.4, 33.3, and 49 .7 nmol/g of the mesh). Briefly, to fabricate PSP-17 membrane, 966 mg of PLCL (Mn = 198 kDa, PDI = 1.90) and 34 mg of PLCL-SP copolymers were added. For PSP-34, and PSP-50 membranes, 69.1 mg and 103 mg of PLCL-SP copolymers were added, respectively. Noticeably, one mg of PLCL-SP copolymer contains 0.4827 nmol of SP as evaluated by amino acid analysis (Shafiq et al., 2015b) . PSP-17, PSP-34, and PSP-50 identification codes have been used in the manuscript, which correspond to 16.4, 33.3, and 49.7 nmol/g of SP in the mesh, respectively. Electrospinning was performed by a custom-made ES setup using the following conditions: 9 % w/v solution in HFIP, needle-collector distance of 18 cm, flow rate of 1 mL/h, voltage of 18 kV, and a 21-gauge needle. The needle was clamped to the positive electrode of a high voltage power supply, and the negative electrode was connected to a rotating aluminium drum collector (250 rpm). Solution was delivered using a syringe pump (ESP200D, NanoNC). Electrospun nanofibres were dried in a vacuum oven at ambient temperature for 3 d, and stored in a desiccator for subsequent use.
Characterisation of PLCL and PLCL-SP copolymers Gel permeation chromatography
The molecular weight of linear and star-shaped PLCL copolymers was analysed by gel permeation chromatography (Viscotek GPCmaxVE 2001, Houston, TX, USA) equipped with micro-styragel columns calibrated with polystyrene. Chloroform was used as the mobile phase, with a flow rate of 1.0 mL/min at 40 °C.
Amino acid analysis
To evaluate the conjugation of SP with star-shaped PLCL copolymers, amino acid composition analysis was carried out according to previously published protocol (Chun et al., 2009; Shafiq et al., 2015b) . Briefly, the conjugate sample was dissolved in CHCl 3 and then dried for hydrolysis. Samples were hydrolysed in 6 N hydrochloric acid at 110 °C for 24 h, and then derived by phenylisothiocyanate (20 μL of methanol: water: triethylamine: phenylisothiocyanate in the ratio 7:1:1:1). After micro-centrifugation of the derived conjugate sample, supernatant was filtered with a 0.45 mm filter and analysed by a high-pressure liquid chromatography (HPLC) equipped with a C18 column (Waters Nova-Pak C18, 3.9 × 300 mm, 4 µm), oven (46 °C), injector (HP 1100 series, Auto sampler), pump (HP 1100 series, binary pump), and variable wavelength detector (HP 1100 series). The solvent system (solvent A: 140 mM sodium acetate buffer, 0.15 % triethylamine, 6 % acetonitrile, 0.03 % ethylenediaminetetraacetic acid (EDTA), pH 6.1 and solvent B: 60 % acetonitrile, 0.015 % EDTA) consisted of the linear gradient (0-100 %) of solvent B. The samples were detected at 254 nm at the flow rate of 0.4 mL/min and injection volumes of 2 µL for a standard curve, and 10 µL for samples, to determine the amounts of each amino acid. Mole fraction of each amino acid was calculated by comparing with the peak area from standard (250 pmol).
Morphological analysis of electrospun nonwoven meshes
The morphology of ES nonwoven meshes was characterised by field emission scanning electron microscope (Hitachi S-4200, Hitachi High-Technologies, Tokyo, Japan). All samples were sputter coated with gold prior to analysis. The diameter of the fibres was calculated using Image J and presented as mean ± standard deviation of 70 fibres.
M Shafiq et al. PLCL scaffolds for in situ tissue regeneration
In vitro release kinetics of SP from electrospun nonwoven meshes To analyse the release kinetics of SP from PLCL/PLCL-SP meshes, samples (n = 3, area = 1 × 1 cm 2 ) were placed in 50 mL plastic tubes, and 600 μL of release medium (0.1 % bovine serum albumin in PBS) was added to each tube . Samples were incubated at 37 °C with shaking at 100 rpm up to 30 d. At pre-determined time points, media were collected and replaced with fresh media to provide infinite sink conditions to the samples. The cumulative amount of SP released to the media was evaluated using a SP enzyme-linked immunosorbent assay (ELISA) Development Kit (R&D Systems, Minneapolis, MN, USA) following the manufacturer's instructions.
In vitro Trans-well migration assay
The migratory response of human MSCs (hMSCs) (passage 6) towards PLCL, SP, and PLCL/PLCL-SP was analysed using Millipore QCM™ 24-well cell migration assay (ECM508, Millipore, Billerica, MA) following manufacturer's instructions with slight modifications . Human MSCs (Centre for Regenerative Medicine, Texas A&M University, College station, TX, USA) were expanded at 37 °C, 5 % CO 2 in Dulbecco's Modified Eagle Medium (Life technologies, Waltham, MA) supplemented with foetal bovine serum (10 %) and penicillin/streptomycin (1 %) and passaged at 70 % confluence using 0.25 % Trypsin-EDTA (Invitrogen) (Phadke et al., 2013) . Collagen type 1A (BD, Franklin Lakes, NJ; 0.1 mg/mL in acetic acid) was added in the inserts and the plate was incubated at 37 °C with 5 % CO 2 for 2 h.
After washing three times with PBS, 300 μL of cell suspension (1 × 104 cells) in serum-free medium was added to the inserts. Cells were homogenised for 48 h in an incubator . About 250 μL of SP solution (0.1 mg/mL in deionised water), PLCL or PLCL/ PLCL-SP nonwoven meshes (diameter = 15 mm, weight ~ 1.5 mg) were placed in the wells. About 500 μL of the media was added in the inserts, and the Trans-well plate was incubated at 37 °C for 48 h. Following manufacturer's instructions, inserts were washed and cells were stained. Cells were observed using light microscopy (Eclipse TE2000U; Nikon, Tokyo, Japan).
Fabrication of vascular scaffolds
Nonwoven meshes were treated with 70 % ethanol overnight, and then dried for 2 d at room temperature. The dried nonwoven meshes were sterilised using ethylene oxide gas at 1.0 bar and 35 °C (E.O Gas Sterilizer, PERSON-E035/50, PERSON Medical, Korea). The sterilised meshes were coated with collagen solution (1 mg/mL in acetic acid) and incubated at 4 °C overnight (Mun et al., 2012) . To remove residual solution, collagencoated meshes were washed three times with PBS. Vascular scaffolds (inner diameter = 4 mm, wall thickness ~ 200 μm) were fabricated from membranes using a scaffold-membrane approach, whereby membranes were rolled around a sterilised silicon tube ten times (Fig. 1C ) (Mun et al., 2012) . About 5 µL of fibrin gel was used to join the layers only at the 2 nd and 10 th layer of the scaffolds. Under aseptic conditions, a longitudinal incision was made in the dorsal skin of the rats, and a muscle pocket was created using blunt scissors, without injuring the deep muscle. Scaffolds were implanted in the space between the skin and deep muscle. Two samples were implanted per animal on the right and left side of the incision, and the skin was sutured using 3-0 cm silk sutures. After 14 or 28 d, animals were sacrificed, and samples were explanted. Because easy isolation of the surrounding tissues from the samples was not possible, the vascular grafts along with the surrounding tissues were explanted. The explanted samples were fixed in 10 % formalin for 24 h, embedded in a mixture of paraffin and ethylene vinyl acetate (5:1) and stored at −20 °C for analysis. Paraffin blocks were sectioned into slices (thickness = 6 μm) for histological and immunofluorescence staining.
Implantation of scaffolds
Characterisation of explanted grafts Histological analysis of the explanted grafts
The cell infiltration and tissue regeneration abilities of the retrieved scaffolds were assessed using histological examination. Histological analysis of the retrieved grafts was carried with haematoxylin and eosin staining and Masson's trichrome (MT) staining using standard protocols (Go et al., 2008; Choi et al., 2008) . With MT staining, connective tissues were stained blue, nuclei were stained dark red/purple, and cytoplasm was stained red/pink. The stained sections were observed by light microscopy (Eclipse TE2000U; Nikon, Tokyo, Japan). The dashed lines in Fig. 4 (as well as in subsequent figures) represent the boundaries between the surrounding tissues and the scaffolds, whereas "L" represents lumen of the graft.
Evaluation of angiogenesis and stem cell recruitment in vivo
For immunostaining, anti-CD90/CD105 antibody, mouse anti-rat CD68 antibody (MCA341R, AbD Serotec, NC, USA), rabbit anti-von Willebrand Factor antibody (vWF, Abcam, Cambridge, MA, USA), and anti-laminin antibody (Sigma Aldrich, ST. Louis, MO, USA) were used. Paraffin sections were deparaffinised, rehydrated, and blocked using 4 % BSA in PBS for 1 h at room temperature. For CD90 and CD105 immunostaining, the sections were incubated with anti-CD90 antibody (1:400 dilution) and anti-CD105 antibody (1:200 dilution) diluted with blocking serum at room temperature for 2 h, washed with PBS three times,
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and then treated with Alexa 488-conjugated goat antimouse antibody or Alexa 594-conjugated goat anti-rabbit antibody (1:400 dilution; Invitrogen). For staining cellular nuclei, 4',6-diamidino-2-phenylindole (DAPI; 1:1000, Life Technologies, Carlsbad, CA, USA) was applied before confocal imaging. For laminin immunostaining, sections were incubated with the rabbit anti-laminin antibody (1:25 dilution), followed by Alexa 594-conjugated goat antirabbit antibody. As described, this was followed by DAPI for nuclear staining. Similar procedure was followed for the immunostaining of vWF and CD68. For vWF staining, the sections were incubated with vWF antibody (1:400 dilution), followed by Alexa Flour 594 conjugated goat anti-rabbit antibody (1:200). For CD68 staining, sections were incubated with mouse anti-rat CD68 antibody (1:100) followed by Alexa Flour 594 conjugated rabbit anti-mouse antibody (1:200). The stained sections were observed using fluorescence microscopy (Eclipse TE2000U; Nikon, Tokyo, Japan). The numbers of positive cells were counted in three randomly selected images from both the interior and periphery regions of the retrieved scaffolds. The counts were averaged and are presented as means ± SD. For blood vessel quantification, the confocal images (laminin-positive cells or blood vessels) were analysed with Image J software (U.S. National Institutes of Health, Bethesda, MD, USA) using the "analyze particle".
Statistical analysis
All quantitative results were obtained from at least three samples for analysis using Image J 1.43 (National Institute of Mental Health, Bethesda, MD, Image Pro version 4.5, Media Cybernetics, Silver Spring, MD, USA). Data were expressed as the mean ± standard deviation. A two-tailed student's t-test was used to compare data from different groups. A value of p < 0.05 was considered statistically significant.
Results
Linear PLCL and PLCL-SP were synthesised using our previously published article and the purity was confirmed (Jeong et al., 2004; Shafiq et al., 2015a) .
Morphology of electrospun non-woven meshes
Nanofibres were fabricated by electrospinning PLCL and PLCL-SP copolymer blends onto a rotating mandrel. Morphology of the fibres and dimensions were characterised by SEM. Scanning electron microscopy images of electrospun mats are shown in Fig. 2 , revealing the nonwoven nanofibrous morphology of PLCL as well as PLCL/ PLCL-SP meshes with interconnected pores. Uniform, continuous, and smooth nanofibres without bead defects and exhibiting a well-defined morphology were formed. PLCL nanofibres (the control group) showed uniform morphology and smooth surfaces. Moreover, fibre size was uniform, and no fusion was observed among the fibres. The average diameter of the fibres was 1.077 ± 0.181 μm.
The PLCL/PLCL-SP meshes were also homogeneous and uniform in size. In addition, no adherence was observed between the nanofibres. The average diameter of PSP-17, PSP-34, and PSP-50 fibres was 0.690 ± 0.098 μm, 0.604 ± 0.092 μm, and 0.502 ± 0.100 μm, respectively (Fig. 2b) .
In vitro release kinetics of Substance P from nonwoven meshes
The in vitro release profile of SP from the electrospun mats (n = 3) was measured using ELISA kit (Fig. 3a, b) . Electrospun mats containing covalently conjugated SP showed a cumulative release of 1389.3 ± 60.7 pg/mL (PSP-17), 1434.9 ± 42.4 pg/mL (PSP-34), and 1351.8 ± 40.3 (PSP-50) of SP over 30 d (Fig. 3a) . These values correspond to 2.05 ± 0.19, 0.93 ± 0.19, and 1.00 ± 0.11 % of the initially loaded SP released from the PSP-17, PSP-34, and PSP-50 meshes, respectively, during this time point (Fig. 3b) .
In vitro Trans-well migration assay
The ability of SP, PLCL, and PLCL/PLCL-SP to induce chemotaxis towards hMSCs was evaluated using an in vitro Trans-well migration assay. The results confirmed that many cells migrated through the membrane pores by the action of soluble SP or PLCL/PLCL-SP mats compared with the control group (Student's t-test, p < 0.05). As shown in Fig. 3 , only few cells migrated to the lower part of the membrane in the control group. By contrast, significantly greater number of cells migrated (Student's t-test, p < 0.05) to the lower surface of membrane in response to SP. PLCL/ PLCL-SP meshes also significantly (n = 6, p < 0.05) induced the migration of hMSCs to the lower part of the membrane compared with the control group. The numbers of migrated cells were quantified and the graph was shown in Fig 3c. The numbers of migrated cells were as follows: PLCL, 15.33 ± 2.88; PSP-17, 20.8 ± 2.98; PSP-34, 41.8 ± 4.38; PSP-50, 57.8 ± 4.02; SP, 68.1 ± 6.69 (Fig. 3c) . It was observed that meshes containing higher content of SP recruited more cells. These results demonstrated that the bioactivity of SP was preserved, which may be a critical factor for in vivo application and evaluation.
Characterisation of explanted grafts
Haematoxylin and eosin staining After 14 or 28 d of implantation, the scaffolds had adhered to the surrounding or subcutaneous tissues. The representative micrographs of histological sections of explanted samples are shown in Fig. 4 . Both scaffold types showed an increase in cell infiltration with implantation time. The sections showed regeneration of vascular tissues and infiltration of host cells. In the control and PSP-17 groups, cells only slightly infiltrated into the grafts, which were mainly confined at the tissue-scaffold boundary 14 d after implantation (Fig. 4a, b) . Moreover, granular tissues were observed near the tissue-scaffold interface in these groups. The interior portion of the PLCL graft was devoid of cells, whereas, few cells were seen in the inner site of the PSP-17 graft. By contrast, cell infiltration in the PLCL/ PLCL-SP scaffolds (PSP-34 and PSP-50) was much more pronounced 14 d after implantation (Fig. 4c, d ). In these groups, infiltrating cells were observed throughout the cross-section of the grafts and homogeneously distributed within the graft wall, and granular tissues were formed (Fig. 4c, d ). For the 28-day implantation, only few cells 
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existed in the central region of the control, whereas significantly more cells were found in the central region of the PSP-17 and PSP-34 scaffolds. The significantly more homogeneous cell infiltration in the bulk of the PLCL/ PLCL-SP vascular scaffolds implanted for 28 d may be attributed to the gradual migration and proliferation of infiltrating host cells. Consequently, granular tissues were formed to a large extent in these SP groups. PSP-50 showed less cellularity at this time point. Several categories of host cells such as fibroblasts, myofibroblasts, vascular cells, and macrophages may have infiltrated into the grafts from the adjacent tissues or arteries (as described in the next sections). We also assessed inflammatory response to these scaffolds and found that only few CD68 + cells were accumulated in the control and SP groups at both time points.
Histology of scaffolds implanted in vivo
Collagen was detected in the bulk of control and PLCL/ PLCL-SP scaffolds implanted for 14 d and 28 d (Fig. 5) . Collagen deposition was observed in the PLCL scaffolds implanted for 14 d, suggesting that the infiltrating fibroblasts remained viable and functional, contributing to the regeneration of neotissues (Fig. 5a ). On the other hand, the PSP-17 scaffold showed less deposition of collagen compared with the control group at this time point, which was attributed to the low numbers of infiltrated cells (Fig. 5b) . Collagen fibres were observed throughout the cross-section of PSP-34 and PSP-50 scaffolds after 14 d of implantation (Fig. 5c, d) . Control, PSP-17, and PSP-34 grafts explanted 28 d after implantation showed a large amount of collagen deposition compared with grafts retrieved 14 d after implantation (Fig. 5) . PSP-50 showed slightly less collagen deposition at day 28 than that at day 14. Subsequently, the levels of collagen deposited in the tissues were examined by measuring the integrated optical density of trichrome stained images. A graph quantifying these results is shown in Fig. 5e . As can be seen from the figure, PSP-17 showed less deposition of collagen than the control group did. PSP-34 and PSP-50 scaffolds showed significantly higher amounts of collagen deposition compared with the control group (Student's t-test, p < 0.05).
Effect of SP on stem cell recruitment in vivo
We further characterised the response of host stem cells to PLCL and PLCL/PLCL-SP grafts in vivo and evaluated whether stem cells resided in or surrounded the vascular scaffolds. We performed immunofluorescence staining of the explants with MSC-specific markers (CD90 and CD105) 14 and 28 d after implantation. Fig. 6 shows the representative micrographs of implanted grafts in the control and SP groups that have been immunostained for CD90 antibody. The control group showed only few CD90 + cells at 4 weeks after implantation. On the other hand, the retrieved scaffolds in the SP group contained many CD90 + cells. We also performed immunostaining for CD105 in the grafts explanted 14 and 28 d after implantation (Fig.7) . The control group did not show CD105 + cells while in contrast, CD105 + cells were observed in the SP groups. To quantify these results, the number of CD90 + and CD105 + cells was counted in the merged images and shown in Fig. 8a-b 
Angiogenesis in the explanted grafts
The angiogenesis in the implanted scaffolds was evaluated by immunostaining for laminin. Fig. 9 show the confocal images of control and SP groups retrieved after 14 and 28 d that were immunostained with laminin. Very few laminin-positive blood vessels were found in the controls implanted for 14 and 28 d. However, significant growth of blood vessels occurred in the PLCL/PLCL-SP vascular scaffolds implanted for 14 and 28 d (Student's t-test, n = 6, p < 0.05). The numbers of laminin-positive blood vessels were counted and shown in Fig. 8c .
Evaluation of endothelial cells
The samples were stained for an endothelial cell marker, Von Willebrand factor (vWF), to further identify the types of infiltrating cells and to evaluate the extent of angiogenesis. In a comparison of the control and SP groups, the number of vWF + blood vessels and cells was significantly higher in the grafts containing SP at all time points (student's t-test, p < 0.05) (Fig. 10 ). Very few vWF + blood vessels were observed in the controls implanted for 14 and 28 d. The scaffolds containing SP (PSP-17) showed a larger number of vWF + blood vessels and cells than that in the control group. However, the interior of these grafts was free of vWF + vessels and cells. Of note, many vWF Blood vessels were seen at the tissue/scaffold interface in the control and PSP-17 groups. In contrast, PSP-34 and PSP-50 grafts showed large number of laminin + blood vessels compared with the control group (n = 6, p < 0.05). Of studied groups, PSP-34 group showed the highest numbers of blood vessels formation at both time points. Scale bars, 100 μm.
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Evaluation of inflammatory macrophages
We also performed immunostaining of explanted scaffolds with the pan macrophage marker "CD68" to evaluate the inflammatory response and the confocal micrographs obtained are shown in Fig. 11 . Both PLCL and PLCL/ PLCL-SP scaffolds showed only few CD68 + cells 14 d after implantation. The number of CD68 + cells was higher 28 d after implantation. We also quantified the number of CD68 + cells and the results are shown in Fig. 8e .
Discussion
Recently, in situ TE approaches for artificial blood vessels have been reported, and these systems were shown to induce vascular regeneration through endogenous cell recruitment. In addition to various chemotactic agents such as G-CSF, GM-CSF, and SDF-1α, SP has been suggested as a new potential bioactive molecule that can accelerate tissue regeneration through endogenous cell mobilisation and immune-modulatory mechanisms Amadesi et al., 2012; Kim et al., 2015) . Substance P exerts its effects by preferentially binding to and activating the tachykinin receptor neurokinin 1 (NK1) receptor (Amadesi et al., 2012) . In previous studies, SP has either been encapsulated in hydrogels or immobilised on pre-fabricated sponges and scaffolds. However, these approaches only minimally allow for large-scale processing manipulation.
Therefore, we emphasise the conjugation of SP with PLCL in bulk to achieve effective delivery for an extended period and the fabrication of ES scaffolds as artificial vascular grafts from this modified copolymer. PLCL-SP provides local delivery of SP in scaffolds, which can induce tissue regeneration via the local and systematic cellular and immune-modulatory effects of SP. We fabricated PLCL/ PLCL-SP scaffolds containing different doses of SP to provide a series of scaffolds. Nanofibres were found to be smooth and homogeneous. The fibrous structure stimulates the microstructure of native arteries and allows the integration of the scaffold with the surrounding cells and native arteries. The average diameter of the fibres increased in the following order: PSP-50 < PSP-34 < PSP-17 < control. This might be due the addition of low molecular weight PLCL-SP copolymer. Our results also indicate that SP was released in a sustained fashion and the released amount of SP was comparable in the three groups. In vitro, SP might be released from the meshes as a result of hydrolysis. During in vivo implantation, PLCL is degraded hydrolytically and enzymatically (Jeong et al., 2004) . These results indicate that the meshes containing covalently conjugated SP can provide long-term persistence of this biomolecule in vivo, which can be very effective for cell recruitment, proliferation, and/or differentiation. Because SP has a very short half-life in vitro and is rapidly degraded by enzymes, it is imperative to design suitable biomaterials that can preserve its bioactivity and enhance its in vivo stability . In previous reports from our group, we found that long-term and localised persistence . Evaluation of CD68 + macrophages in PLCL and PLCL/ PLCL-SP scaffolds after 2 weeks (upper panel) and 4 weeks ( l o w e r p a n e l ) o f implantation. Arrows point at the CD68 + c e l l s . S c a f f o l d s e x p l a n t e d a t 4 weeks showed more macrophages than at 2 weeks. Scale bars, 50 μm.
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PLCL scaffolds for in situ tissue regeneration of SP in self-assembling peptides enhanced ischemic revascularisation and bone regeneration Kim et al., 2015) . This study has demonstrated that the bioactivity of SP was preserved and scaffolds containing SP significantly induced the migration of hMSCs in vitro compared with the negative control (Fig. 3) . Quantitative analysis showed that the extent of hMSC recruitment was dependent on SP content in different meshes. Our results are consistent with those from previous studies Amadesi et al., 2012; Kim et al., 2015) . Cell infiltration is the initial step with a critical role in the subsequent regeneration of vascular grafts through processes such as vascularisation, ECM secretion, and deposition (Zilla et al., 2007) . Limited cell infiltration often prevents the long-term regeneration and remodelling process of vascular grafts (de Valence et al., 2012) . To address this issue, two strategies have been adopted to date. One is to focus on rapid degradation, whereas the second is to increase the pore size of the scaffolds. The space generated during degradation promotes cell infiltration and tissue regeneration (Wu et al., 2012) . Since PLCL (50:50) is a biodegradable copolymer, it will be degraded and sorbed after implantation. Consequently, host cells can infiltrate into the grafts and induce vascular regeneration. Our data demonstrated that cells only slightly infiltrated into the control and PSP-17 grafts. Of these grafts, PSP-17 showed lower cell infiltration 14 d after implantation, which might be due to smaller diameter of nanofibres (Fig.  4b) . It has been documented that cellular infiltration into ES scaffolds is often impeded by the high packing density of the fibres (Balguid et al., 2009 ). The experimental evidence indicated a significant enhancement of cell infiltration in the PSP-34 and PSP-50 grafts. Homogeneous cell distribution was achieved in these groups 14 d after implantation. While SP-containing groups possess almost similar morphology, the higher cell population of PSP-34 and PSP-50 grafts might be attributed to the role of SP in enhancing host cell recruitment, proliferation, and/or differentiation (Kohara et al., 2010; Kim et al., 2014; La et al., 2014; Hong et al., 2015) . Since our system enables the localised presence of SP in the scaffold, we expect that it might have produced a favourable microenvironment for host cell infiltration as well as for their proliferation and differentiation, thus enhancing reparative effects . We speculate that several types of cells such as fibroblasts, myofibroblasts, macrophages, vascular cells, and stem cells, can infiltrate into the scaffolds. These cells may be mobilised from resident tissues, circulation, or BM. Indeed, our results indicate the presence of ECs, MSCs, and few CD68 + macrophages. Deposition, remodelling, and organisation of the ECM by fibroblasts are essential functions for tissue growth. Histological trichrome staining performed to identify the presence of collagen in the scaffolds showed more collagen deposition in the PSP-34 and PSP-50 groups than in the controls and PSP-17. These results suggest that infiltrated cells were functional and secreted ECM. Indeed, SP is assumed to enhance the healing process partly by stimulating the proliferation of fibroblasts, myofibroblasts, and notably stem/progenitor cells, in turn leading to enhanced collagen formation and organisation (Nilsson et al., 1985; Carlsson et al., 2011; Hong et al., 2009) . PSP-17 scaffolds showed slightly lower collagen deposition than the controls did 14 d after implantation, which was attributed to the accumulation of only few cells and less cell proliferation (Fig. 5b) . Immune-modulatory response was assessed by pan-macrophage staining in the scaffolds. Although significant differences between the numbers of macrophages in the control and SP groups were not observed 14 d after implantation, slightly more macrophages were observed in PSP-34 than in the controls implanted for 28 d. Further identification of macrophage phenotypes is needed to define the dominant activity of infiltrating macrophages.
Previous studies have documented that the SP gradient between circulation and BM resulted in the recruitment of NK1 + stem/progenitor cells towards damaged tissues, and that these cells promoted ischemic revascularisation and tissue regeneration Amadesi et al., 2012; Kim et al., 2014; Noh et al., 2015) . This study confirmed that the scaffolds containing SP recruited MSCs in vivo and that these scaffolds were more effective in MSC recruitment than the control groups were at all observed time points. PSP-34 grafts showed a higher number of MSCs 14 and 28 d after implantation. Unexpectedly, fewer numbers of cells were observed in PSP-50 28 d after implantation, which may be due to an inhibitory or toxic effect of the higher concentration of SP by this time point. However, further studies are warranted to confirm this speculation. Potentially, such cell recruitment could be augmented or differentiated into various lineages by providing suitable signalling molecules (Amadesi et al., 2012; Hong et al., 2015) . Given that SP induces the differentiation of stem cells into multiple lineages, the localised presence of SP within the vascular scaffolds could endow a suitable microenvironment for vascular regeneration (Fu et al., 2014; Noh et al., 2015) . Though the exact origin of the recruited cells is not yet known, these cells might have been recruited from the BM, circulation, or adipose tissues Ko et al., 2012; Mun et al., 2013) .
Scaffold vascularisation was examined by immunostaining explanted scaffolds for laminin and Von Willebrand factor (vWF) that is a mandatory prerequisite for functional tissues. After implantation, all infiltrating cells depend on adequate supplies of oxygen and nutrients for survival. Therefore, it is critical for scaffold to develop sufficient vasculature. The control and PSP-17 groups showed blood vessel ingrowth mainly at the tissue-scaffold interface, whereas the PSP-34 scaffold showed evidence for angiogenesis throughout the cross-section. PSP-50 showed less vascularisation 28 d after implantation than observed after 14 d, which may be due to an inhibitory or toxic effect of SP (Fig. 8c) . Further studies are needed confirm this. Thus, the incorporation of PLCL-SP in the scaffolds could enhance angiogenesis possibly through the enhanced recruitment of MSC, which gives rise to therapeutic potential in TE. We speculate that the beneficial effects of scaffolds containing SP are as a result of (1) their MSC-recruiting ability with angiogenic capability, and (2) the long-term release of SP. It has been reported that SP not only recruits MSC, but also various angiogenic cells
PLCL scaffolds for in situ tissue regeneration in vitro and in vivo that have been shown to participate in angiogenesis (Ziche et al., 1990; Hong et al., 2009; Kohara et al., 2010; Kim et al., 2013) . Overall it is possible that recruited stem cells, progenitor cells, or vascular cells proliferated and sometimes differentiated, inducing angiogenesis . These neo-vessels might have formed from the recruitment of ECs and SMCs from adjacent vessel segments. Furthermore, host-derived cells may participate in the formation of neo-vessel through a paracrine mechanism by initiating an immune-modulatory cytokine cascade necessary for vascular neotissues formation, including the proliferation and migration of ECs and SMCs in addition to ECM production and tissue regeneration.
In summary, we have demonstrated that TEVGs incorporated with PLCL-SP have the ability to grow, repair, and remodel. While this study demonstrated the potential of SP in enhancing tissue regeneration in ES scaffolds, the strategy can be extended to other biomaterial scaffolds for applications such as cartilage TE, bone TE, and wound healing. Future developments of this method may allow SP as well as other peptides or growth factors to be conjugated with other synthetic or natural polymeric materials. Different combinations of regulatory signals, including growth factors, cell adhesion molecules, or a balanced combination of the two, can be conjugated with the activated functional groups of the star-shaped PLCL to simultaneously enhance stem cell mobilisation, homing, and angiogenesis. These materials can be fabricated into different shapes and structures such as, membranes, spheres, and scaffolds as needed for the TE of additional organs and tissues to improve tissue repair. The SP-conjugated polymers can be directly electrospun or printed (using 3D printing) to yield off-the-shelf small-diameter vascular grafts. Thus, the current study provides a promising solution for the sustained signalling of neuropeptides in ES meshes to promote stem cell recruitment, which might be critical for in situ tissue regeneration.
Our study has limitations in that we evaluated the performance of the 3D scaffolds after subcutaneous implantation. When implanted as a vascular substitute, the grafts would be in an environment that is completely different from that after simple subcutaneous implantation. Therefore, the characterisation of these grafts as vascular substitutes will further delineate the potential of this strategy. Therefore, this study warrants the assessment of these TEVGs as vascular interposition grafts in flow conditions. In particular, a careful elucidation of stenosis, aneurismal dilation, rupture, and thrombosis will clarify the potential of our strategy in the development of TEVGs. Recently, it has been shown that macrophages and their phenotypes are essential for tissue regeneration, neovascularisation, and graft complications such as stenosis. Detailed characterisations of macrophages and their phenotypes may be another direction of this study.
Conclusion
In the current study, we have developed electrospun scaffolds containing different concentrations of SP (16.4, 33.3, and 49.7 nmol/g of the mesh) to fabricate vascular grafts, and evaluated their performance in vitro and in vivo. ELISA revealed the sustained release of SP and in vitro cell migration assay showed the recruitment of hMSCs towards SP containing electrospun mats. The 3D scaffolds containing SP showed significantly higher host cell infiltration, blood vessel formation, and MSC recruitment in vivo compared with the control group. Of the investigated groups, PSP-34 showed higher cell infiltration, MSC recruitment, and blood vessel formation. The strategy adopted here could be employed to functionalise polymeric biomaterials to induce stem cell recruitment and promote blood vessel formation.
